Together these findings indicate that the cancer-specific overexpression of Tβ10 by Ad.TERT.Tβ10 could indeed be a valuable anti-cancer therapeutic for the treatment of ovarian cancer without toxicity to normal cells and possibly other malignancies. Here, TERT is linked to cancer.